RxSight Inc RXST
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.80
- Day Range
- $4.69–4.94
- 52-Week Range
- $4.48–14.88
- Bid/Ask
- $4.59 / $5.00
- Shares Outstanding
- 41.40M
- Market Cap
- $194.98M
- Volume/Avg
- 1M / 783,437
Key Statistics
- Price/Earnings (Normalized)
- 474.40
- Price/Sales
- 1.55
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 461
- Website
- https://www.rxsight.com
Valuation
|
Metric
|
RXST
|
|---|---|
Price/Earnings (Normalized) | 474.40 |
Price/Book Value | 0.74 |
Price/Sales | 1.55 |
Price/Cash Flow | — |
Price/Earnings
RXST
Financial Strength
|
Metric
|
RXST
|
|---|---|
Quick Ratio | 8.78 |
Current Ratio | 10.20 |
Interest Coverage | −3,255.71 |
Quick Ratio
RXST
Profitability
|
Metric
|
RXST
|
|---|---|
Return on Assets (Normalized) | −6.80% |
Return on Equity (Normalized) | −7.64% |
Return on Invested Capital (Normalized) | −9.75% |
Return on Assets
RXST
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Zpyypkg | Nrfygc | $155B | |||
| Stryker Corp
SYK
| Xdsvwssjv | Dtxn | $118B | |||
| Medtronic PLC
MDT
| Ksmcyfppg | Dmtsc | $103B | |||
| Boston Scientific Corp
BSX
| Vtlrmbzp | Fsynt | $70B | |||
| Edwards Lifesciences Corp
EW
| Lcplcgjy | Thcfyvt | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Gpwkdvrq | Rgxt | $30B | |||
| DexCom Inc
DXCM
| Ybgjbhrxtb | Rpmdfg | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Yhj | Rgcs | $26B | |||
| Steris PLC
STE
| Pdmdbrc | Hfydh | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Zmqnbvlmys | Zdcmy | $17B |
United States